As the science behind a novel approach to treating disease evolves, the focus of research and clinical development is expanding from rare conditions to far more common diseases.
Dublin, Nov. (GLOBE NEWSWIRE) -- "RNAi Drug Delivery - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global RNAi drug delivery market, valued at US$1.1 ...
Single administration of CIDEB siRNA resulted in rapid, deep and durable reductions in liver fat by up to 80% that were ...
RNAi adoption accelerates through precision targeting, improved delivery, personalized medicine, agricultural innovation, regulatory approvals and robust funding.Dublin, Nov. 12, 2026 (GLOBE NEWSWIRE) ...
Researchers have developed a transgenic short hairpin RNA platform in Drosophila melanogaster that selectively degrades endogenous histone transcripts while allowing engineered, RNAi-insensitive ...
RNA interference (RNAi) is a fascinating biological process in worms, plants, fungi, and metazoans that has been a valuable tool for studying gene function and as therapeutics. In Caenorhabditis ...
RNA interference (RNAi) acts like a "gene switch," selectively silencing specific genes. It uses specialized RNA molecules, such as small interfering RNA (siRNA) or microRNA (miRNA), to block genetic ...
Please provide your email address to receive an email when new articles are posted on . The receptor for advanced glycation end-products (RAGE) regulates pathways that contribute to inflammation.
RNA interference is a natural mechanism for living cells to control whether specific genes are being used or not. Crowned with the 2006 Nobel Prize for Physiology and Medicine, the discovery of RNA ...
A genome-wide investigation identified twenty-three core RNA interference genes in Brassica rapa, mapping their evolutionary relationships, conserved catalytic domains, subcellular distributions, and ...